A researcher is conducting research on behalf of a medical company. After testin

Question

A researcher is conducting research on behalf of a medical company. After testing the equipment with one hundred patients, he realizes that the equipment being marketed is defective and in 25% of the cases, the equipment can fail and lead to death.

a. What should the researcher do?

b. In this instance what do you think would be classified as ‘ethical misconduct’?

c. The researcher is of the opinion that he can discard the research and attempt it again using a different set of patients. Explain whether or not this is the right thing to do.

Explanation / Answer

Explanation:

A - Researchers should have to notify the top management of the company and make sure that top management don't launch thier product in market. The product is defective and can even cause death to people so he should have to inform the related agency and company and save the innocent customers.

B - If researcher give nod to product and let the company launch the product in market, that would be considered as ethical misconduct as to thier knowledge they launched the product and put the customers in harms way.

C - This would be also be an unethical act as the first research showed that it can cause even death to people, with this information the second attempt to try it on different patients would be inhuman act and against the ethics and immorale act. Certain steps should not be allowed again.

Related Questions

Navigate

• Browse (All)
• Browse A
• Subjects

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.